Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
Data to be presented at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting on November 7th and 9thBOSTON and ...
Just off I-70, crews are putting some of final touches on the Mighty Argo Cable Car, a new gondola that will carry visitors ...
PepGen shifts focus to PGN-EDODM1 for Myotonic Dystrophy Type 1 after discontinuing PGN-EDO51 for Duchenne Muscular Dystrophy ...
A collaborative study published today in the journal Cell Reports provides evidence for a new molecular cause for neurodegeneration in Alzheimer’s disease. The study, led by researchers at Baylor ...
Obtained ex-US Regulatory Clearance for DT-818, a Potentially Best-in-Disease Treatment for Myotonic Dystrophy Type-1 (DM1) Trials of DT-216P2 in Friedreich Ataxia (FA) and DT-168 in Fuchs Endothelial ...
A splicing factor drives gene expression down multiple paths in T cells. The factor, an mRNA-binding protein called CELF2, has been known to affect mRNA processing in neuronal and muscle cells. But ...
A new Northwestern University study using patient nervous tissue and lab-grown human neurons has uncovered how a key disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback